Printer Friendly

Browse Crizotinib topic


1-67 out of 67 article(s)
Title Author Type Date Words
Factors Impacting Clinically Relevant RNA Fusion Assays Using Next-Generation Sequencing. Ramani, Nisha S.; Patel, Keyur P.; Routbort, Mark J.; Alvarez, Hector; Broaddus, Russell; Chen, Hui; Report Nov 1, 2021 6231
Ideaya Biosciences announces $80M common stock offering. Jul 6, 2021 200
Ideaya Reports Darovasertib Monotherapy Overall Survival Data. Apr 19, 2021 564
Ideaya Biosciences announces data from ongoing darovasertib, binimetinib trial. Apr 16, 2021 512
Next generation sequencing detection in archival surgically resected lung adenocarcinoma specimens harbouring the anaplastic lymphoma kinase fusion protein. Jiang Zhiming; Li Chenghui; Lu Hongyang Report Feb 28, 2021 3618
Pfizer's Xalkori Approved by FDA for ALK-positive Anaplastic Large Cell Lymphoma in Children and Young Adults. Jan 15, 2021 534
Anticolon Cancer Properties of Pyrazole Derivatives Acting through Xanthine Oxidase Inhibition. Alsayari, Abdulrhman; Asiri, Yahya I.; Muhsinah, Abdullatif Bin; Hassan, Mohd. Zaheen Jan 1, 2021 2901
Non-Small Cell Lung Cancer: Part II. Lacovara, Jane; Bohnenkamp, Susan Column Jan 1, 2021 1966
Ideaya, Pfizer expand collaboration for IDE196 and crizotinib study. Sep 24, 2020 301
FDA Accepts Supplemental New Drug Application for Pfizer's Xalkori for the Treatment of Pediatric ALK-positive Anaplastic Large Cell Lymphoma. Sep 23, 2020 432
Relationship between IL10 and PD-L1 in Liver Hepatocellular Carcinoma Tissue and Cell Lines. Qian, Qian; Wu, Changping; Chen, Jianping; Wang, Weibing Report Jul 31, 2020 6558
Inflammatory Myofibroblastic Tumor: A Rare Presentation and an Effective Treatment with Crizotinib. Khalil, Sumaira; Ghafoor, Tariq; Raja, Amna Kaneez Fatima Jul 31, 2020 3930
Turning Point Therapeutics presents preclinical data on repotrectinib. Jun 22, 2020 386
Correlation of ROS1 Immunohistochemistry With ROS1 Fusion Status Determined by Fluorescence In Situ Hybridization. Huang, Richard S.P.; Smith, Derek; Le, Catherine H.; Liu, Wen-Wei; Ordinario, Ellen; Manohar, Chitra Jun 1, 2020 5662
UPDATE: Medicines Committee Recommends Roche Rozlytrek EU Approval. May 29, 2020 238
FDA approves Takeda's Alunbrig as first-line treatment for rare lung cancer. May 22, 2020 191
miR-30a-5p Inhibits Proliferation and Migration of Lung Squamous Cell Carcinoma Cells by Targeting FOXD1. Chen, Chunhua; Tang, Junhua; Xu, Shan; Zhang, Wenxia; Jiang, Hanliang Apr 30, 2020 4764
Clinicopathological characteristics of patients with surgically resected lung cancer having tumours harboring anaplastic lymphoma kinase fusion protein. Chen, Bo; Jiang, Zhiming; Li, Chenghui; Lu, Hongyang Report Apr 30, 2020 1951
Turning Point announces publication of data from Phase 1 of TRIDENT-1 study. Apr 16, 2020 254
European Commission Approves Takeda's Alunbrig as a First-Line Treatment for ALK+ NSCLC. Apr 8, 2020 865
Successful Treatment of Crizotinib-Induced Fulminant Liver Failure: A Case Report and Review of Literature. Kreitman, Kyle; Nair, Satheesh P.; Kothadia, Jiten P. Mar 31, 2020 2833
Identifying Tumorigenesis and Prognosis-Related Genes of Lung Adenocarcinoma: Based on Weighted Gene Coexpression Network Analysis. Yi, Ming; Li, Tianye; Qin, Shuang; Yu, Shengnan; Chu, Qian; Li, Anping; Wu, Kongming Mar 1, 2020 5111
Detection of ALK Gene Rearrangement in Cell-free RNA from Lung Cancer Malignant Pleural Effusion. Chu, Mingliang; Zhu, Yanqiu; Hu, Jianjun; Zhang, Zhuxue; Luo, Meng; Ma, Xiaobo Mar 1, 2020 2354
The Value of Next-Generation Sequencing for Treatment in Non-Small Cell Lung Cancer Patients: The Observational, Real-World Evidence in China. Zhang, Yan; Shen, Wen-Xiang; Zhou, Li-Na; Tang, Min; Tan, Yue; Feng, Chun-Xia; Li, Ping; Wang, Li-Qi Mar 1, 2020 4100
OncoMyx Therapeutics Forms Scientific Advisory Board. Jan 14, 2020 644
Inflammatory Myofibroblastic Tumor. Greenhill, Mark; Aria, David; Schaefer, Carrie; Kaye, Robin; Jorgensen, Scott A.; Abruzzo, Todd; Tow Jan 1, 2020 1427
Simultaneous Quantification of Brigatinib and Brigatinib-Analog in Rat Plasma and Brain Homogenate by LC-MS/MS: Application to Comparative Pharmacokinetic and Brain Distribution Studies. Li, Bo; Lu, Min; Jin, Lei; Zheng, Maoen; Sun, Peilu; Lei, Shanshan; Xiong, Shan; Chen, Suhong Dec 31, 2019 5367
Current Landscape of Epigenetics in Lung Cancer: Focus on the Mechanism and Application. Shi, Yuan-Xiang; Sheng, De-Qiao; Cheng, Lin; Song, Xin-Yu Dec 31, 2019 8385
Global Soft Tissue Sarcoma (STS) Market Insights, Epidemiology, and Market Forecast 2019-2028. Dec 16, 2019 859
Upper Gastrointestinal Bleed due to Duodenal Metastases of Lung Adenocarcinoma: Report of Two Cases and Review of Literature. Kosasih, Sumitro; Nawawi, Khairul Najmi Muhammad; Wong, Zhiqin; Hsin, Deborah Chew Chia; Ban, Andrea Report Nov 30, 2019 2426
Pfizer Inc. (NYSE: PFE). Oct 28, 2019 4348
Pfizer UK. Oct 22, 2019 4379
Pfizer Inc (NYSE: PFE). Oct 21, 2019 4348
Pfizer UK. Oct 15, 2019 4379
Pfizer Inc (NYSE: PFE). Oct 14, 2019 4271
Pfizer Inc (NYSE: PFE). Oct 7, 2019 4271
Pfizer Inc (NYSE: PFE). Oct 1, 2019 4271
Pfizer UK. Sep 24, 2019 4379
Roche to present new data from its broad oncology portfolio at the European Society for Medical Oncology 2019 Congress. Sep 23, 2019 1237
Paperwork, High Costs Could Mean Worse Survival for Lung Cancer Patients. Norton, Amy Report Sep 3, 2019 722
Brain Metastasis Mimicking Brain Abscess in ALK-Positive Non-Small-Cell Lung Cancer. Sakatani, Toshio; Kage, Hidenori; Takayanagi, Shunsaku; Watanabe, Kaoru; Hiraishi, Yoshihisa; Shinoz Jul 31, 2019 1449
Multiple Molecular Targets Associated with Genomic Instability in Lung Cancer. Soca-Chafre, Giovanny; Montiel-Davalos, Angelica; De La Rosa-Velazquez, Inti Alberto; Caro-Sanchez, Jul 31, 2019 5383
Combining breast, lung cancer drugs to treat cancer yields better results: study. Jul 12, 2019 489
Signet Ring Cell Carcinoma of the Lung: A Diagnostic Pitfall in Pregnancy. Danzinger, Sabine; Kostler, Wolfgang J.; Funovics, Martin; Herac, Merima; Mullauer, Leonhard; Prosch Jun 30, 2019 5430
Survival and Cost-Effectiveness of Trabectedin Compared to Ifosfamide Monotherapy in Advanced Soft Tissue Sarcoma Patients. Verboom, Michiel C.; Gelderblom, Hans; Kerst, J. Martijn; Steeghs, Neeltje; Reyners, Anna K.L.; Slei Jun 30, 2019 8331
New asthma jab and 'gene-silencing' drug approved in Scotland; Healthcare: Five new medicines accepted for use on the NHS. Jun 11, 2019 429
Molecular Testing of Non-Small Cell Lung Carcinoma Diagnosed by Endobronchial Ultrasound-Guided Transbronchial Fine-Needle Aspiration: The Cleveland Clinic Experience. Doxtader, Erika E.; Cheng, Yu-Wei; Zhang, Yaxia Jun 1, 2019 4154
Anticancer Screening of the Phytochemicals Present in the Medicinal Plant Vitex Negundo against Mutant Anaplastic lymphoma Kinase (ALK) Protein: A in-silico Approach. Anusha, D.; Sharanya, S.; Ramya; David, Darling Chellathai Jun 1, 2019 3363
Turning Point Therapeutics announces updated interim TRIDENT-1 data. Clinical report May 31, 2019 442
The European Commission grants conditional marketing authorisation for Pfizer's LORVIQUA. May 10, 2019 196
The European Commission grants conditional marketing authorisation for Pfizer's LORVIQUA. May 10, 2019 192
European Commission Approves Lorviqua for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer. May 10, 2019 450
Pfizer says EC grants conditional marketing authorization for LORVIQUA. May 7, 2019 201
Pharmacokinetic Study and Tissue Distribution of Lorlatinib in Mouse Serum and Tissue Samples by Liquid Chromatography-Mass Spectrometry. Chen, Wei; Shi, Yafei; Qi, Shuya; Zhou, Haiyan; Li, Chunyu; Jin, Dujia; Li, Guohui Mar 31, 2019 4498
European Medicines Agency's committee recommends Pfizer's lung cancer drug. Mar 5, 2019 184
European Medicines Agency's committee recommends Pfizer's lung cancer drug. Mar 5, 2019 188
Pfizer Receives Positive CHMP Opinion for Lorviqua for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer. Mar 4, 2019 444
Pfizer receives positive opinion for LORVIQUA from CHMP. Mar 1, 2019 127
National lung cancer screening programme could save Kiwi lives. Mar 1, 2019 961
In NSCLC, Longer Survival With Brigatinib Than Crizotinib; Longer progression-free survival in those with ALK-positive dz who did not previously take ALK inhibitor. Oct 15, 2018 257
Anti-PD-1/PD-L1 Therapy for Non-Small-Cell Lung Cancer: Toward Personalized Medicine and Combination Strategies. Sui, Hongshu; Ma, Ningxia; Wang, Ying; Li, Hui; Liu, Xiaoming; Su, Yanping; Yang, Jiali Clinical report Jan 1, 2018 12468
Epigenetic versus Genetic Deregulation of the KEAP1/NRF2 Axis in Solid Tumors: Focus on Methylation and Noncoding RNAs. Fabrizio, F.P.; Sparaneo, A.; Trombetta, D.; Muscarella, L.A. Jan 1, 2018 13066
Sclerotic Bone Metastasis in Pulmonary Adenocarcinoma. Hammamy, Riyadh Ali Mohammed; Farooqui, Khalid; Ghadban, Wisam Case study Jan 1, 2018 1720
DNA Nanotweezers with Hydrolytic Activity for Enzyme-Free and Sensitive Detection of Fusion Gene via Logic Operation. Xu, Yongjie; Luo, Xiangrong; Geng, Nana; Wu, Mingsong; Lu, Zhishun Jan 1, 2018 4703
Resolution of Crizotinib-Associated Fulminant Hepatitis following Cessation of Treatment. Charville, Gregory W.; Padda, Sukhmani K.; Sibley, Richard K.; Puthillath, Ajithkumar; Kwo, Paul Y. Jan 1, 2018 2940
Design, Synthesis, and Anticancer Activities of Novel 2-Amino-4-phenylthiazole Scaffold Containing Amide Moieties. Zhang, Zhi-Hua; Wu, Hong-Mei; Deng, Sai-Nan; Cai, Xiao-Yu; Yao, Yu; Mwenda, Muriira Cyrus; Wang, Jin Jan 1, 2018 7170
War on cancer. Moss, Ralph Dec 1, 2011 2436

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |